Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies

Brechbiel, 1991 Brechbiel, 1986, Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor imaging studies, Inorg. Chem., 25, 2772, 10.1021/ic00236a024 Carrasquillo, 1988, Radioimmunoscintigraphy of colon cancer with I-131-labeled B72.3 monoclonal antibody, J. Nucl. Med., 29, 1022 Colcher, 1981, A spectrum of monoclonal antibodies reactive with mammary tumor cells, 78, 3199 Colcher, 1987, Quantitative analysis of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patients, Cancer Res., 47, 1185 DeNardo, 1982, The choice of radionuclides for radioimmunotherapy Deshpande, 1990, Yttrium-90 labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent, J. Nucl. Med., 31, 473 Durbin, 1960, Metabolic characteristics within a chemical family, Hlth Phys., 2, 225, 10.1097/00004032-195907000-00001 Esteban, 1987, Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3, Int. J. Cancer, 39, 50, 10.1002/ijc.2910390110 Esteban, 1987, New method for the chelation of indium-111 to monoclonal antibodies: biodistribution and imaging of athymic mice bearing human colon carcinoma xenografts, J. Nucl. Med., 28, 861 Halpern, 1983, Labeling of monoclonal antibodies with indium-111: technique and advantages compared to radioiodine labeling, 197 Hnatowich, 1982, The preparation and labeling of DTPA-coupled albumin, Int. J. Appl. Radiat. Isot., 33, 327, 10.1016/0020-708X(82)90144-2 Hnatowich, 1988, Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody, J. Nucl. Med., 29, 1428 Hnatowich, 1985, Pharmacokinetics of an indium-111 labeled monoclonal antibody in cancer patients, J. Nucl. Med., 26, 849 Horan Hand, 1983, Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor associated antigens, Cancer Res., 43, 728 Johnson, 1986, Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3, Cancer Res., 46, 850 Jowsey, 1958, The deposition of the rare earths in bone, Radiat. Res., 8, 490, 10.2307/3570441 Kozak, 1989, Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity, Cancer Res., 49, 2639 Krejcarek, 1977, Covalent attachment of chelating groups to macromolecules, Biochem. Biophys. Res. Commun., 77, 581, 10.1016/S0006-291X(77)80018-1 Mach, 1981, Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy, Immunol. Today, 2, 239, 10.1016/0167-5699(81)90011-6 Maguire, 1989, Immunoscintigraphy of colorectal adenocarcinoma: results with site-specifically radiolabeled B72.3 (111In-CYT-103), Antibody Immunoconjug. Radiopharmaceut., 2, 257 Mansi, 1989, Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using [131I]B72.3, Nucl. Med. Biol., 16, 127 Molinolo, 1990, Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoptein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue, Cancer Res., 50, 1291 O'Brien, 1983, Overview of radionuclides useful for radioimmunoimaging/radioimmunotherapy and current status of preparing radiolabeled antibodies, 161 O'Mara, 1968, Rare earth nuclides as potential agents for skeletal imaging, J. Nucl. Med., 10, 49 Ohuchi, 1987, Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas, Int. J. Cancer, 40, 726, 10.1002/ijc.2910400603 Order, 1986, 90Yttrium antiferritin. A new therapeutic radiolabeled antibody, Int. J. Radiat. Oncol. Biol. Phys., 12, 277, 10.1016/0360-3016(86)90110-0 Roselli, 1989, Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts, J. Nucl. Med., 30, 672 Roselli, 1991 Scheinberg, 1983, Kinetic and catabolic considerations of monoclonal antibody targeting in erythroleukemic mice, Cancer Res., 43, 265 Schlom, 1989, Tumor targeting with monoclonal antibody B72.3, Nucl. Med. Biol., 16, 137 Sheer, 1988, Purification and composition of the human tumor-associated glycoprotein (TAG-72) defined by monoclonal antibodies CC49 and B72.3, Cancer Res., 48, 6811 Sickle-Santanello, 1987, Radioimmunoguided surgery using the monoclonal antibody B72.3 in colorectal tumors, Dis. Colon Rectum, 30, 761, 10.1007/BF02554623 Stramignoni, 1983, Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas, Int. J. Cancer, 31, 543, 10.1002/ijc.2910310504 Thor, 1987, Monoclonal antibody B72.3 reactivity with human endometrium: a study of normal and malignant tissues, Int. J. Gynecol. Pathol., 6, 235, 10.1097/00004347-198709000-00005 Thor, 1986, Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3, J. Natl. Cancer Inst., 76, 995 Thor, 1986, Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3, Cancer Res., 46, 3118 Wessels, 1984, Radionuclide selection and model absorbed dose calculation for radio-labeled tumor associated antibodies, Med. Phys., 11, 638, 10.1118/1.595559 Wolf, 1989, Detection of the tumor-associated glycoprotein antigen (TAG-72) in premalignant lesions of the colon, J. Natl. Cancer Inst., 81, 1913, 10.1093/jnci/81.24.1913 Yokoyama, 1989, Differences in biodistribution of indium-111- and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer, J. Nucl. Med., 30, 320